4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-023862
CEO sold 8,582 shares at $18.16 ($155,849)
- CEO acquired 17,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2023-04-05 | Option exercise | +17,333 | 109,060 | D | ||
| DAVIS STEPHEN CEO | 2023-04-06 | Sale | −8,582 | $18.16 | $155,849 | 100,478 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2023-04-05 | Option exercise · Restricted Stock Units | −17,333 | 52,000 | D | ||
| Open-market sales · 8,582 sh · avg $18.16 · $155,849 | |||||||
Loading xslF345X04/doc4.xml…